lOMoAR cPSD| 32744169
TestnBanknfornIntroductorynClinicalnPharmacologyn12thnEditionnFor
d
Introductory Clinical Pharmacol
n n
ogy 12th Edition FordTest Bank
n n n n n
, lOMoAR cPSD| 32744169
TestnBanknfornIntroductorynClinicalnPharmacologyn12thnEditionnFor
d
1. Annursingninstructornisnpreparingnanteachingnplannfornangroupnofnnursingnstudentsnaboutnph
armacology.nWhenndescribingnthisntopic,ntheninstructornwouldnfocusnthendiscussionnonnwh
ichnofnthenfollowingnasnannessentialnaspect?
A) Drugnname
B) Drugnclass
C) Drugnaction
D) Drugnsourcen
Ans:n CnFeedbac
k:
Pharmacologynisnthenstudynofndrugsnandntheirnactionnonnlivingnorganisms.nThus,nanness
entialnaspectnofnpharmacologynisndrugnaction.nAnnunderstandingnofnthendrugnname,ndru
gnclass,nandndrugnsourcenisnimportant,nbutnthenmostncriticalnaspectnrelatedntonpharmacol
ogynisnhownthendrugnactsninnthenbody.
2. Annursingnstudentnisnpreparingntonadministernanprescribedndrugntonanpatient.nThenstudentnre
viewsninformationnaboutnthendrugnandnitsnactions.nWhichnofnthenfollowingnwouldnbenthenbes
tnchoicenfornobtainingnthisninformation?nSelectnallnthatnapply.
A) Nursingninstructor
B) Nursenassignedntonthenpatient
C) Clinicalndrugnreference
D) Prescribingnhealthncarenprovider
E) Clinicalnpharmacistn
Ans:n C,nE
Feedback:
Althoughnthennursingnstudentncannasknthennursingninstructor,nthennursenassignedntonthenpati
ent,nandnthenprescribingnhealthncarenprovidernforninformationnaboutnthendrug,nthenbestnchoi
cesnforndrugninformationnwouldnincludenannappropriatendrugnreferencenandnthenclinicalnph
armacist.
3. Whenndescribingnthenvariousntypesnofnmedicationsntonangroupnofnnursingnstudents,nann
ursingninstructornwouldnidentifynwhichnofnthenfollowingnasnansourcenfornderivingnme
dications?nSelectnallnthatnapply.
A) Plants
B) Syntheticnsources
C) Mold
D) Minerals
E) AnimalsnAns
:nA,nB,nC,nD,nEnFeed
back:
Medicationsnarenderivednfromnnaturalnsources,nfornexample,nplants,nmolds,nminerals,nandna
nimals,nasnwellnasncreatednsyntheticallyninnanlaboratory.
Pagen 1
, lOMoAR cPSD| 32744169
TestnBanknfornIntroductorynClinicalnPharmacologyn12thnEditionnFor
d
4. Whichnofnthenfollowingnnamesnmaynbenassignedntonandrugnduringnthenprocessnofnd
evelopment?nSelectnallnthatnapply.
A) Chemicalnname
B) Officialnname
C) Pharmacologicnname
D) Tradenname
E) Nonproprietarynnamen
Ans:n A,nB,nD,nEnFeedback
:
Throughoutnthenprocessnofndevelopment,ndrugsnmaynhavenseveralnnamesnassignedntonthemn
includingnanchemicalnname,nangenericn(nonproprietary)nname,nannofficialnname,nandnantrade
nornbrandnname.
5. Andrugnmaynbenclassifiednbynwhichnofnthenfollowing?nSelectnallnthatnapply.
A) Thenchemicalntypenofnthendrug'snactiveningredient
B) Thenwaynthendrugnisnusedntontreatnanspecificncondition
C) Thengenericnnamenofnthendrug
D) Thentradennamenofnthendrug
E) Thennonproprietarynnamenofnthendrugn
Ans:n A,nB
Feedback:
Andrugnmaynbenclassifiednbynthenchemicalntypenofnthenactiveningredientnornbynthenwaynitnisnu
sedntontreatnanparticularncondition.nGeneric,ntrade,nandnnonproprietarynreferntonhownandrugni
snnamed.
6. Angroupnofnnursingnstudentsnarenreviewingninformationnaboutnthenprocessnofndrugndeve
lopmentninnthenUnitednStates.nThenstudentsndemonstratenunderstandingnofnthisnprocessn
whenntheynidentifynthatnwhichnofnthenfollowingncategoriesnarenassignednbynthenFoodnand
nDrugnAdministrationntonnewlynapprovedndrugs?nSelectnallnthatnapply.
A) Metabolite
B) Noncontrollednsubstance
C) Prescription
D) Nonprescription
E) Controllednsubstancen
Ans:n C,nD,nE
Feedback:
Oncendrugsnarenapprovednfornuse,nthenFDAnassignsnthendrugntononenofnthenfollowingncate
gories:nprescription,nnonprescription,norncontrollednsubstance.nMetabolitenrefersntontheni
nactivenformnofnthendrug.nNoncontrollednsubstancenisnantermnthatnisnnotnused.
Pagen 2
, lOMoAR cPSD| 32744169
TestnBanknfornIntroductorynClinicalnPharmacologyn12thnEditionnFor
d
7. Whichnofnthenfollowingnwouldnbenmostnimportantnfornthennursentondontonensurenthensafenu
senofnprescriptionndrugsninntheninstitutionalnsetting?nSelectnallnthatnapply.
A) Administeringndrugs
B) Monitoringnclientsnforndrugneffects
C) Prescribingndrugs
D) Evaluatingnclientsnforntoxicneffects
E) Educatingnclients/caregiversnaboutndrugsn
Ans:n A,nB,nD,nE
Feedback:
Inntheninstitutionalnsetting,nthennurse'snrolentonensurensafenusenofnprescriptionndrugsninclu
desnadministeringndrugs,nmonitoringndrugneffects,nevaluatingnforntoxicneffects,nandneduca
tingnclientsnandncaregiversnaboutndrugs.
8. Thennursenisnhelpingnanclientnreviewnanprescriptionnfromnthenhealthncarenprovider.nWhenne
xaminingnthenprescription,nwhichnofnthenfollowingnwouldnthennursenexpectntonfindndocum
ented?nSelectnallnthatnapply.
A) Namenofnthendrug
B) Dosagenofnthendrug
C) Routenofndrugnadministration
D) Timesnofndrugnadministration
E) Licensednprescriber'snsignaturen
Ans:n A,nB,nC,nD,nE
Feedback:
Thenprescriptionnmustncontainnthenclient'snname,nthennamenofnthendrug,nthendosage,nthen
methodnandntimesnofnadministration,nandnthensignaturenofnthenlicensednhealthncarenprovi
dernprescribingnthendrug.
9. Afternteachingnangroupnofnnursingnstudentsnaboutnnonprescriptionndrugs,nthennursingninstr
uctorndeterminesnthatnthenteachingnwasnsuccessfulnwhennthenstudentsnidentifynwhichnofnth
enfollowing?nSelectnallnthatnapply.
A) Theynrequirenanlicensednhealthncarenprovider'snsignature.
B) Theynarenreferredntonasnover-the-counterndrugs.
C) Theyncannbentakennwithoutnriskntonthenclient.
D) Theynhavencertainnlabelingnrequirements.
E) Theynshouldnbentakennonlynasndirectednonnthenlabel.n
Ans:n B,nD,nE
Feedback:
Nonprescriptionndrugsnarenoftennreferredntonasnover-the-
countern(OTC)ndrugs.nTheyndonnotnrequirenanprescriptionn(anlicensednhealthncarenprovider'
snsignature)nbutndonnotncomenwithoutnriskntonthenclient.nThenfederalngovernmentnhasnimpos
ednlabelingnrequirementsnofnOTCndrugsnandntheynshouldnonlynbentakennasndirectednonnthenl
abelnunlessnundernthensupervisionnofnanhealthncarenprovider.
Pagen 3
TestnBanknfornIntroductorynClinicalnPharmacologyn12thnEditionnFor
d
Introductory Clinical Pharmacol
n n
ogy 12th Edition FordTest Bank
n n n n n
, lOMoAR cPSD| 32744169
TestnBanknfornIntroductorynClinicalnPharmacologyn12thnEditionnFor
d
1. Annursingninstructornisnpreparingnanteachingnplannfornangroupnofnnursingnstudentsnaboutnph
armacology.nWhenndescribingnthisntopic,ntheninstructornwouldnfocusnthendiscussionnonnwh
ichnofnthenfollowingnasnannessentialnaspect?
A) Drugnname
B) Drugnclass
C) Drugnaction
D) Drugnsourcen
Ans:n CnFeedbac
k:
Pharmacologynisnthenstudynofndrugsnandntheirnactionnonnlivingnorganisms.nThus,nanness
entialnaspectnofnpharmacologynisndrugnaction.nAnnunderstandingnofnthendrugnname,ndru
gnclass,nandndrugnsourcenisnimportant,nbutnthenmostncriticalnaspectnrelatedntonpharmacol
ogynisnhownthendrugnactsninnthenbody.
2. Annursingnstudentnisnpreparingntonadministernanprescribedndrugntonanpatient.nThenstudentnre
viewsninformationnaboutnthendrugnandnitsnactions.nWhichnofnthenfollowingnwouldnbenthenbes
tnchoicenfornobtainingnthisninformation?nSelectnallnthatnapply.
A) Nursingninstructor
B) Nursenassignedntonthenpatient
C) Clinicalndrugnreference
D) Prescribingnhealthncarenprovider
E) Clinicalnpharmacistn
Ans:n C,nE
Feedback:
Althoughnthennursingnstudentncannasknthennursingninstructor,nthennursenassignedntonthenpati
ent,nandnthenprescribingnhealthncarenprovidernforninformationnaboutnthendrug,nthenbestnchoi
cesnforndrugninformationnwouldnincludenannappropriatendrugnreferencenandnthenclinicalnph
armacist.
3. Whenndescribingnthenvariousntypesnofnmedicationsntonangroupnofnnursingnstudents,nann
ursingninstructornwouldnidentifynwhichnofnthenfollowingnasnansourcenfornderivingnme
dications?nSelectnallnthatnapply.
A) Plants
B) Syntheticnsources
C) Mold
D) Minerals
E) AnimalsnAns
:nA,nB,nC,nD,nEnFeed
back:
Medicationsnarenderivednfromnnaturalnsources,nfornexample,nplants,nmolds,nminerals,nandna
nimals,nasnwellnasncreatednsyntheticallyninnanlaboratory.
Pagen 1
, lOMoAR cPSD| 32744169
TestnBanknfornIntroductorynClinicalnPharmacologyn12thnEditionnFor
d
4. Whichnofnthenfollowingnnamesnmaynbenassignedntonandrugnduringnthenprocessnofnd
evelopment?nSelectnallnthatnapply.
A) Chemicalnname
B) Officialnname
C) Pharmacologicnname
D) Tradenname
E) Nonproprietarynnamen
Ans:n A,nB,nD,nEnFeedback
:
Throughoutnthenprocessnofndevelopment,ndrugsnmaynhavenseveralnnamesnassignedntonthemn
includingnanchemicalnname,nangenericn(nonproprietary)nname,nannofficialnname,nandnantrade
nornbrandnname.
5. Andrugnmaynbenclassifiednbynwhichnofnthenfollowing?nSelectnallnthatnapply.
A) Thenchemicalntypenofnthendrug'snactiveningredient
B) Thenwaynthendrugnisnusedntontreatnanspecificncondition
C) Thengenericnnamenofnthendrug
D) Thentradennamenofnthendrug
E) Thennonproprietarynnamenofnthendrugn
Ans:n A,nB
Feedback:
Andrugnmaynbenclassifiednbynthenchemicalntypenofnthenactiveningredientnornbynthenwaynitnisnu
sedntontreatnanparticularncondition.nGeneric,ntrade,nandnnonproprietarynreferntonhownandrugni
snnamed.
6. Angroupnofnnursingnstudentsnarenreviewingninformationnaboutnthenprocessnofndrugndeve
lopmentninnthenUnitednStates.nThenstudentsndemonstratenunderstandingnofnthisnprocessn
whenntheynidentifynthatnwhichnofnthenfollowingncategoriesnarenassignednbynthenFoodnand
nDrugnAdministrationntonnewlynapprovedndrugs?nSelectnallnthatnapply.
A) Metabolite
B) Noncontrollednsubstance
C) Prescription
D) Nonprescription
E) Controllednsubstancen
Ans:n C,nD,nE
Feedback:
Oncendrugsnarenapprovednfornuse,nthenFDAnassignsnthendrugntononenofnthenfollowingncate
gories:nprescription,nnonprescription,norncontrollednsubstance.nMetabolitenrefersntontheni
nactivenformnofnthendrug.nNoncontrollednsubstancenisnantermnthatnisnnotnused.
Pagen 2
, lOMoAR cPSD| 32744169
TestnBanknfornIntroductorynClinicalnPharmacologyn12thnEditionnFor
d
7. Whichnofnthenfollowingnwouldnbenmostnimportantnfornthennursentondontonensurenthensafenu
senofnprescriptionndrugsninntheninstitutionalnsetting?nSelectnallnthatnapply.
A) Administeringndrugs
B) Monitoringnclientsnforndrugneffects
C) Prescribingndrugs
D) Evaluatingnclientsnforntoxicneffects
E) Educatingnclients/caregiversnaboutndrugsn
Ans:n A,nB,nD,nE
Feedback:
Inntheninstitutionalnsetting,nthennurse'snrolentonensurensafenusenofnprescriptionndrugsninclu
desnadministeringndrugs,nmonitoringndrugneffects,nevaluatingnforntoxicneffects,nandneduca
tingnclientsnandncaregiversnaboutndrugs.
8. Thennursenisnhelpingnanclientnreviewnanprescriptionnfromnthenhealthncarenprovider.nWhenne
xaminingnthenprescription,nwhichnofnthenfollowingnwouldnthennursenexpectntonfindndocum
ented?nSelectnallnthatnapply.
A) Namenofnthendrug
B) Dosagenofnthendrug
C) Routenofndrugnadministration
D) Timesnofndrugnadministration
E) Licensednprescriber'snsignaturen
Ans:n A,nB,nC,nD,nE
Feedback:
Thenprescriptionnmustncontainnthenclient'snname,nthennamenofnthendrug,nthendosage,nthen
methodnandntimesnofnadministration,nandnthensignaturenofnthenlicensednhealthncarenprovi
dernprescribingnthendrug.
9. Afternteachingnangroupnofnnursingnstudentsnaboutnnonprescriptionndrugs,nthennursingninstr
uctorndeterminesnthatnthenteachingnwasnsuccessfulnwhennthenstudentsnidentifynwhichnofnth
enfollowing?nSelectnallnthatnapply.
A) Theynrequirenanlicensednhealthncarenprovider'snsignature.
B) Theynarenreferredntonasnover-the-counterndrugs.
C) Theyncannbentakennwithoutnriskntonthenclient.
D) Theynhavencertainnlabelingnrequirements.
E) Theynshouldnbentakennonlynasndirectednonnthenlabel.n
Ans:n B,nD,nE
Feedback:
Nonprescriptionndrugsnarenoftennreferredntonasnover-the-
countern(OTC)ndrugs.nTheyndonnotnrequirenanprescriptionn(anlicensednhealthncarenprovider'
snsignature)nbutndonnotncomenwithoutnriskntonthenclient.nThenfederalngovernmentnhasnimpos
ednlabelingnrequirementsnofnOTCndrugsnandntheynshouldnonlynbentakennasndirectednonnthenl
abelnunlessnundernthensupervisionnofnanhealthncarenprovider.
Pagen 3
